SYRS - Syros Pharmaceuticals, Inc.
IEX Last Trade
0.214
0 0%
Share volume: 6,782
Last Updated: Thu 26 Dec 2024 08:22:22 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$0.21
0.00
0.00%
Summary score
31%
Profitability
25%
Dept financing
22%
Liquidity
66%
Performance
31%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2020 - 30-Jun-2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-34.97%
Return on assets
-16.56%
Return on sales
-709.23%
Return on invested capital
9959.14%
Total debt ratio
63.55%
Debt ratio change over timeo
-0.86%
Current Ratio
5.11%
Quick Ratio
5.11%
Cash Position Ratio
4.89%
Short-term ratios 30-Jun-2023 - 30-Jun-2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-38.6%
Return on assets
-21.64%
Return on sales
-3918.07%
Return on invested capital
662.3%
Total debt ratio
90.08%
Debt ratio change over timeo
-0.01%
Current Ratio
3.68%
Quick Ratio
3.68%
Cash Position Ratio
3.47%
Last quarter ratios 30-Jun-2024
The data are presented for the financials results of the last quarter.
Return on equity
367.24%
Return on assets
-25.69%
Return on sales
0%
Return on invested capital
857.61%
Total debt ratio
105.95%
Debt ratio change over time
-0.78%
Current Ratio
3.46%
Quick Ratio
3.46%
Cash Position Ratio
3.22%
Performance ratios (change over 4 years) 30-Jun-2020 - 30-Jun-2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-187.79%
Return on assets
-102.06%
Return on sales
-1880.12%
Return on invested capital
58.02%
Total debt ratio
-85.64%
Debt ratio change over time
-0.86%
Current Ratio
-1.21%
Quick Ratio
-1.21%
Cash Position Ratio
-1.21%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | SYRS | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -34.97% | 15.05% | 35.64% | 7.13% |
| Return on assets | -16.56% | 2.88% | 3.13% | 5.53% |
| Return on sales | -709.23% | 29.62% | 32.25% | 40.49% |
| Return on invested capital | 9959.14% | 2.57% | 5.37% | 18.48% |
| Profitability | 25% | 42% | 59% | 55% |
| Total debt ratio | 63.55% | 90.48% | 91% | 25.78% |
| Debt ratio change over time | -0.86% | 326.95% | -8.44% | 1.18% |
| Dept financing | 17% | 50% | 25% | 7% |
| Current Ratio | 3.68% | 0.92% | 1.98% | 5.39% |
| Quick Ratio | 3.68% | 0.81% | 1.56% | 4.63% |
| Cash Position Ratio | 3.47% | 0.39% | 1.05% | 2.91% |
| Liquididy | 75% | 10% | 22% | 53% |
| Short-term ratios | SYRS | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -38.6% | 13.14% | 10.88% | 4.07% |
| Return on assets | -21.64% | 2.1% | 1.54% | 3.03% |
| Return on sales | -3918.07% | 21.74% | 18.43% | 30.26% |
| Return on invested capital | 662.3% | 1.95% | 2.74% | 9.55% |
| Profitability | 25% | 60% | 49% | 58% |
| Total debt ratio | 90.08% | 92.68% | 93.24% | 21.84% |
| Debt ratio change over time | -0.01% | 51.04% | -101.54% | 1.43% |
| Dept financing | 24% | 50% | 25% | 7% |
| Current Ratio | 3.68% | 0.92% | 1.98% | 5.39% |
| Quick Ratio | 3.68% | 0.81% | 1.56% | 4.63% |
| Cash Position Ratio | 3.47% | 0.39% | 1.05% | 2.91% |
| Liquididy | 62% | 11% | 25% | 71% |